Keros Therapeutics
Earnings Surprise
Analysts estimated KROS earnings of $-0.64 per share this quarter (Q4). KROS's actual earnings were $-0.86 per share.
KROS EPS surprise of -34.10%Analysts estimated KROS earnings of $-1.07 per share this quarter (Q3). KROS's actual earnings were $-0.18 per share.
KROS EPS surprise of 83.14%Analysts estimated KROS earnings of $-1.15 per share this quarter (Q2). KROS's actual earnings were $-0.76 per share.
KROS EPS surprise of 34.17%Analysts estimated KROS earnings of $-0.25 per share this quarter (Q1). KROS's actual earnings were $3.62 per share.
KROS EPS surprise of 1560.27%Analysts estimated KROS earnings of $-1.00 per share this quarter (Q4). KROS's actual earnings were $-1.14 per share.
KROS EPS surprise of -13.69%Analysts estimated KROS earnings of $-1.30 per share this quarter (Q3). KROS's actual earnings were $-1.41 per share.
KROS EPS surprise of -8.05%Analysts estimated KROS earnings of $-1.37 per share this quarter (Q1). KROS's actual earnings were $-1.21 per share.
KROS EPS surprise of 11.93%Analysts estimated KROS earnings of $-1.40 per share this quarter (Q4). KROS's actual earnings were $-1.34 per share.
KROS EPS surprise of -4.42%Analysts estimated KROS earnings of $-1.37 per share this quarter (Q3). KROS's actual earnings were $-1.33 per share.
KROS EPS surprise of -3.24%